ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10059	Companies
205612	Keywords
135846	Articles
109010	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/22/2025 at 22:00, 11 months ago

Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d’administration
Abivax annonce la nomination du Dr Dominik Höchli au sein de son Conseil d'administration. Expert en immunologie, son arrivée renforce l'équipe à l'approche de la publication des données clés de l'étude de phase 3

Abivax Conseil D'administration Nomination Immunologie Données De Phase 3
PRESS RELEASE

published on 04/22/2025 at 22:00, 11 months ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025

Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF

published on 04/18/2025 at 18:05, 11 months 4 days ago

ABIVAX: Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 04/18/2025 at 18:05, 11 months 4 days ago

ABIVAX : Capital Social et Droits de Vote au 31 Mars 2025

Euronext Paris Droits De Vote Capital Social Actions Abivax
BRIEF

published on 04/18/2025 at 18:05, 11 months 4 days ago

ABIVAX: Détails sur le Capital Social et les Droits de Vote au 31 Mars 2025

Euronext Paris Droits De Vote Capital Social Biotechnologie Abivax
BRIEF

published on 04/18/2025 at 18:05, 11 months 4 days ago

ABIVAX: Details of Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Biotechnology Abivax
PRESS RELEASE

published on 04/18/2025 at 18:00, 11 months 4 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
ABIVAX communique le nombre total d'actions et de droits de vote. La société de biotechnologie Abivax se concentre sur le développement de traitements pour les maladies inflammatoires chroniques

Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
PRESS RELEASE

published on 04/18/2025 at 18:00, 11 months 4 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25.
ABIVAX communique le nombre d'actions et de droits de vote au 31.03.25 conformément aux réglementations de l'AMF

Droits De Vote Actions AMF Abivax Réglementation
BRIEF

published on 03/27/2025 at 18:05, 11 months 26 days ago

ABIVAX : Mise à jour du capital social et des droits de vote

Droits De Vote Capital Social Biotechnologie AMF Abivax
BRIEF

published on 03/27/2025 at 18:05, 11 months 26 days ago

ABIVAX: Update of share capital and voting rights

Share Capital Voting Rights Biotechnology AMF Abivax

Accesswire

Published on 03/20/2026 at 23:00, 2 days ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 2 days 1 hour ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 2 days 1 hour ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 9 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 10 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

EQS Group

Published on 03/22/2026 at 18:22, 4 hours 48 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 10 hours 47 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 2 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 2 days 2 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion

Les Echos

Published on 03/20/2026 at 19:00, 2 days 4 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 4 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 4 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 4 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 5 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE